Robbert Vorhoff
Managing Director and Global Head of Healthcare @ General Atlantic
New York, United States
Robbert Vorhoff is a private equity investor at General Atlantic in New York focused on Health Care and Medical. Robbert Vorhoff is based out of New Orleans, Louisiana and is the Managing Director, Global Head of Healthcare Group of General Atlantic. Robbert previously worked at OneOncology as a Member Board Of Directors. Robbert attended the University of Virginia.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 85%
Last updated:
For AI agents: llms.txt
Industries Robbert Vorhoff invests in
Stages Robbert Vorhoff invests in
Countries Robbert Vorhoff invests in
Round sizes
Round size
- Series D
- $75M–$300M
Investment Focus
Industry
- Health Care 11 (85%)
- Medical 5 (38%)
- Hospital 5 (38%)
- mHealth 2 (15%)
- Therapeutics 2 (15%)
Stage
- Private Equity 5 (38%)
- Series D 3 (23%)
- Seed 1 (8%)
- Series A 1 (8%)
- Series B 1 (8%)
Country
- United States 10 (77%)
- Brazil 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Legent Health
|
Legent Health operates within the healthcare industry, focusing on providing medical and surgical services. The company emphasizes a personalized approach to healthcare, aiming to enhance patient satisfaction beyond traditional medical care. Legent Health is involved in building medical facilities across the country, offering state-of-the-art,minimally invasive treatments. The company prioritizes creating a comfortable environment for patients, with an emphasis on friendly service and patient-centered care. | Private Equity / Oct 15, 2025 | |
U.S. Urology Partners
|
U.S. Urology Partners is a provider of operational support, management expertise, and financial resources for urology practices. The company enables urology groups, large and small, to achieve their goals without losing control and being forced into a subservient role within a hospital system. | Secondary Market / Apr 09, 2025 | |
Vida Health
|
Vida Health is a virtual care platform intentionally designed to treat a person’s whole health by treating mental and physical conditions, together. Vida’s clinically validated approach combines an AI-powered, personalized experience with the support and human connection of coaches and therapists. Vida’s app offers video sessions, messaging, anddigital content to help people prevent, manage, and reverse chronic conditions — like obesity, diabetes and hypertension — and the mental conditions that accompany them — like stress, depression, and anxiety. Some of America’s largest employers and health plans trust Vida’s whole health offering.The company was founded in 2014 and is based in San Francisco, California | $28.5M / Nov 09, 2023 | |
Author Health
|
Author Health is a platform that provides comprehensive care and treatment for Medicare Advantage recipients with substance use disorders and severe mental illnesses. The company offers a team-based approach to care, grouping specialized physicians, therapists, nurses, and community health workers to give a mix of in-person and virtual care forpatients who are often disconnected from the traditional healthcare system. Author Health launched from stealth in 2023 with $115 million in funding led by General Atlantic and Flare Capital Partners. | $115M / Series A / Jun 28, 2023 | |
Biofourmis
|
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effectivesolutions for payers.Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts. | $300M / Series D / Apr 26, 2022 | |
NationsBenefits
|
NationsBenefits® is a leading supplemental benefits company that provides managed care organizations customized healthcare management solutions based on clinically focused interventions that maximize quality and deliver value-based outcomes. | Private Equity / Apr 07, 2022 | |
Stellar Health
|
Stellar Health is a point-of-care, cloud-based platform that activates primary care providers to achieve value-based care (VBC) goals that improve patient outcomes, such as improving quality scores and optimizing the patient care journey through transitions of care and high-value referrals. The Stellar platform helps primary care providerscontinually engage with their patients by providing them real-time information and tangible action-based incentives for improving the quality of care. Stellar Health’s mission is to enable all providers to engage and succeed in VBC by bridging the incentive gap between providers and payors.The company was founded in 2018 and is headquartered in New York, New York. | $60M / Series B / Sep 28, 2021 | |
|
Vida Health
|
Vida Health is a virtual care platform intentionally designed to treat a person’s whole health by treating mental and physical conditions, together. Vida’s clinically validated approach combines an AI-powered, personalized experience with the support and human connection of coaches and therapists. Vida’s app offers video sessions, messaging, anddigital content to help people prevent, manage, and reverse chronic conditions — like obesity, diabetes and hypertension — and the mental conditions that accompany them — like stress, depression, and anxiety. Some of America’s largest employers and health plans trust Vida’s whole health offering.The company was founded in 2014 and is based in San Francisco, California | $110M / Series D / May 05, 2021 | |
Equality Health
|
Equality Health is a Phoenix-based population health risk management company focused on improving care delivery for underserved populations through culturally-sensitive programs that improve access, quality, and patient trust. Through Equality’s integrated technology and services platform, culturally competent physician network, and cultural caremodel the company helps managed care plans and health systems improve care for the Hispanic population while simultaneously making the transition to risk-based accountability. | Private Equity / Jan 26, 2021 | |
Doctor On Demand
|
Doctor On Demand is a video telemedicine company, offering on-demand and scheduled visits with US-licensed healthcare providers via any smartphone, tablet, or computer. It focuses on providing solutions for employers, health plans, retail clinics, and health systems. With solutions for employers, health plans, retail clinics, and health systems,Doctor On Demand is redefining the industry with top-rated customer experience, highest clinical standards, and implementation and customer success directors, as well as 24/7 customer support.The company was founded in 2013 and is headquartered in San Francisco, California. | $75M / Series D / Jul 08, 2020 | |
| See all 13 investments → | |||
Co-Investors
Ally Bridge Group
2 deals together
Canvas Prime
2 deals together
ACME Capital
1 deal together
AME Cloud Ventures
1 deal together
Ardea Partners
1 deal together
Aspect Ventures
1 deal together
About General Atlantic
General Atlantic is a private equity firm that provides capital and strategic support for growth companies. General Atlantic combines a collaborative approach, sector-specific expertise, a long-term investment horizon and a deep understanding of growth drivers to partner with great entrepreneurs and management teams to build market businesses.
General Atlantic Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alex Crisses
Managing Director, Global Head of New Investment Sourcing & Co-Head of Emerging Growth
|
|||
Andrea W. Joseph
Managing Director
|
|||
Andrew Crawford
Managing Director and Global Head of Consumer
|
|||
Asher Hecht
Vice President
|
|||
Ashish Saboo
Managing Director, Chief Representative of Indonesia
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Robbert Vorhoff invest in?
Robbert Vorhoff invests primarily in Health Care, Medical and Hospital startups, most often at Private Equity and Series D stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Robbert Vorhoff's check size?
Robbert Vorhoff typically joins rounds of $75M–$300M at Series D. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Robbert Vorhoff participates in.
When did Robbert Vorhoff last invest?
The most recent investment recorded for Robbert Vorhoff closed in Oct 2025. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
